A carregar...
Characteristics of adverse drug reactions in a vemurafenib early post-marketing phase vigilance study in Japan
BACKGROUND: Post-approval research or monitoring is important to determine real-world safety of new products; however, evidence is scant for vemurafenib in Japanese patients. In Japan, a unique system is officially obligated to investigate post-approval safety. Here we report the first adverse drug...
Na minha lista:
| Publicado no: | Clin Transl Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5797186/ https://ncbi.nlm.nih.gov/pubmed/28674996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-017-1706-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|